Topical Ocular Administration of Progesterone Decreases Photoreceptor Cell Death in Retinal Degeneration Slow (rds) Mice.

Adrián M. Alambiaga-Caravaca,Alicia López-Castellano,Antolín Cantó,Vicent Rodilla,María Miranda

doi:10.3390/ph15030328

Adrián M. Alambiaga-Caravaca, Alicia López-Castellano + Show 3 more

Open Access

https://doi.org/10.3390/ph15030328

Copy DOI

Journal: Pharmaceuticals	Publication Date: Mar 9, 2022
Citations: 3	License type: CC BY 4.0

Affiliation: Universidad Cardenal Herrera CEU

Abstract

Retinitis pigmentosa (RP) is an inherited eye disorder which triggers a cascade of retinal disorders leading to photoreceptor cell death and for which there is currently no effective treatment. The purpose of this research was to study whether ocular administration of a solution of progesterone (PG) in β-cyclodextrins (CD) could delay photoreceptor cell death and counteract the gliosis process in an animal model of RP (rds mice). The possible effect of PG reaching the contralateral eye through the circulatory system was also evaluated. Finally, this research discusses and evaluates the diffusion of the drug from possible topical formulations for ocular administration of PG. A group of rds mice received one drop of a solution of PG in CD every 12 h for 10 days to the left eye, while the right eye was left untreated. Another group of rds mice (control) received the drug vehicle (PBS) on the left eye and, again, the right eye was left untreated. Once the treatment was finished on postnatal day 21, the animals were euthanized and histological immunofluorescence studies (TUNEL, GFAP, and DAPI staining) were carried out. Our results showed that the administration of a solution of PG in CD (CD-PG) as drops significantly decreased cell death and inflammation in the retina of the PG-treated eyes of rds mice. No effect was seen in the contralateral eye from PG that may have entered systemic circulation. In conclusion, CD-PG applied topically as drops to the eye decreases photoreceptor cell death in the early stages of RP, delaying vision loss and decreasing gliosis.

Highlights

Introduction iationsRetinitis pigmentosa (RP) is a group of inherited diseases that produce progressive degeneration of photoreceptor cells advancing eventually towards complete blindness
These results showed a decrease in the photoreceptor cell death in the CD-PG to the left eye (PG-T)
We demonstrated that CD-PG applied in one eye did not affect the non-treated contralateral eye, suggesting that there was no effect derived from topically administered CD-PG on the contralateral eye

Summary

Introduction

Retinitis pigmentosa (RP) is a group of inherited diseases that produce progressive degeneration of photoreceptor cells advancing eventually towards complete blindness. Rods are the first photoreceptor cell type affected by RP, and this results in night blindness and the reduction of the visual field. The death of rod cells leads to a pathological environment in the retina that affects cone photoreceptors and induces the death of the latter cells. In the final stages of this disease, electroretinograms show that the activity of the retina decreases, there is no excitation of the photoreceptors, and the accumulation of pigment deposits (clusters) can be seen in the peripheral retina [1]. RP is a rare disease, it is the most common cause of inherited blindness.

Objectives

Methods

Results

Discussion

Conclusion